Zolbetuximab

ATC L01FX31 · 9 markets · 16 records

Zolbetuximab 9 markets · 16 records Forms

AU 3 records · 3 strengths

100 mginjectionVYLOY zolbetuximab 100 mg vial powder for concentrate for solution for infusion also in GB·TW unknown
300 mginjectionVYLOY zolbetuximab 100 mg vial powder for concentrate for solution for infusion also in GB unknown

Records without a stated strength · 1 VYLOY

US 2 records · 1 strengths

20 mginjectionVYLOY

GB 2 records · 2 strengths

100 mginjectionVyloy 100mg powder for concentrate for solution for infusion vials also in AU·TW
300 mginjectionVyloy 100mg powder for concentrate for solution for infusion vials also in AU

CA 2 records · 2 strengths

300 mgpowderVYLOY
100 mgpowderVYLOY

HK 2 records · 1 strengths

Records without a stated strength · 1 VYLOY Powder for concentrate for solution for infusion 100 mg

SG 1 records · 1 strengths

100 mg/vialinjectionVYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL

TW 1 records · 1 strengths

100 mginjectionVYLOY Powder for concentrate for solution for infusion 100 mg+1威絡益凍晶注射劑100毫克 also in AU·GB

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 VYLOY

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	TW	HK	EU
100 mg injection	not recorded	Vyloy 100mg powder for concentrate for solution for infusion vials	not recorded	VYLOY zolbetuximab 100 mg vial powder for concentrate for solution for infusion	not recorded	VYLOY Powder for concentrate for solution for infusion 100 mg 威絡益凍晶注射劑100毫克	not recorded	not recorded
300 mg injection	not recorded	Vyloy 100mg powder for concentrate for solution for infusion vials	not recorded	VYLOY zolbetuximab 100 mg vial powder for concentrate for solution for infusion	not recorded	not recorded	not recorded	not recorded
100 mg/vial injection	not recorded	not recorded	not recorded	not recorded	VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL	not recorded	not recorded	not recorded
20 mg injection	VYLOY	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg powder	not recorded	not recorded	VYLOY	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg powder	not recorded	not recorded	VYLOY	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	VYLOY	not recorded	not recorded	VYLOY Powder for concentrate for solution for infusion 100 mg	VYLOY

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录（未在本表显示）。另有 1 個規格/劑型僅在 SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.